Background: Incidence of cervical cancer has decreased in the developed world due to use of Pap smear as a screening tool. It has been proven as a sensitive screening tool for cervical cancer but its coverage is very low in Nepal. The objective of this study is to find out the incidence of cervical epithelial cell abnormality, its demographic distribution and common presenting symptoms. Materials and Methods: This retrospective comparative study was conducted in Nobel Medical College and Teaching Hospital, Biratnagar, Nepal. A total of 950 patients attending gynecological department with various symptoms were enrolled. Only 902 patients were included in the study after excluding inadequate samples. Results: The mean age of patient was 37.94 ± 12.74 years with minimum age of 18 and maximum age of 79 years. The mean age of patients with epithelial abnormality was 47.88 ± 8.87 years. The highest number of Atypical squamous cells of undetermined significance was observed between 51-60 years (1.1%) whereas Low and High grade squamous intraepithelial lesion were mostly observed between 41-50 years (3.2% and 0.4% respectively). The most common symptom was vaginal discharge (41.6%) followed by pain abdomen (23.1%). Conclusion: Pap smear is a cost effective, sensitive and simple screening test for cervical premalignant and malignant lesions.
INTRODUCTION
Cervical cancer is the fourth most common cancer amongst women worldwide and second to breast cancer in developing countries and was responsible for 569,847 new cases and 311,365 deaths in 2018 worldwide. 1 According to data of National Cancer Registry Programme (NCRP), cervical cancer is the most common malignancy among women in Nepal. 2 Over 80% of cervical cancers are detected in sub-Saharan Africa in late stages; due to lack of knowledge about the disease and lack of screening services. 3, 4 Women with cervical cancer are not identified until they are at advanced and teaching hospital. Patients with inadequate samples and cervical growth were excluded from the study.
A total of 950 patients had attended gynecological department with various symptoms and were enrolled in our study. Only 902 patients were studied after excluding inadequate samples. The age, parity, age of marriage, age of first childbirth, residency and religion of these patients were recorded in a proforma for demographic comparison. The pap smear was reported according to Bethesda System of Reporting Cervical Cytology 2014.
The findings were categorized as: 1) Negative for malignancy 2) Inflammatory changes 3) Atypical squamous cells of undetermined significance (ASCUS) 4) Low grade squamous intraepithelial lesion (LSIL) and 5) High grade squamous intraepithelial lesion (HSIL).
The results of the study were statistically analyzed using SPSS version 25, using mean ± standard deviation, percentage, frequency and comparative study was done using chi-square test. A p-value of <0.05 was considered statistically significant.
RESULTS
A total of 902 patients were studied after excluding those with inadequate sample. The mean age of the patients was 37.94 ± 12.74 years with minimum age of 18 years and maximum age of 79 years. The highest number of ASCUS was observed in women between 51-60 years (1.1%) whereas LSIL and HSIL were mostly observed in women between 41-50 years (3.2% and 0.4% respectively). Epithelial cell abnormity was found in 8.4% of screened women and in patients with epithelial cell abnormality, 17.11% of patients with parity two or less and 82.89% with parity more than two. Similarly, ASCUS, LSIL and HSIL stages of disease which can be correlated with low survival rates. 5 Cervical cancer can be detected by using several screening techniques. Cervical Pap smear is a sensitive test for early screening of cervical lesions and is the most widely used system. 6 It is stated that the annual incidence and prevalence of cervical cancer has decreased by 50-70% after the introduction of population-based screening. 7 So, if women undergo screening for cervical cancer, it can be detected in early stages thereby reducing the mortality and morbidity. Several studies have stated that the available services provided have not been properly utilized in different countries like Uganda. A recent study conducted found that only 7% of the women had undergone screening for cervical cancer and 4.8% had undergone screening in Eastern Uganda. 8, 9 The National guideline for cervical cancer screening and prevention in Nepal 2010 has 'Visual Inspection of cervix with Acetic Acid' as the screening tool instead of pap smear test. 2 Women of Nepal are getting pap smear test from different health institutes after counseling from health workers. There has been limited studies conducted regarding pap smear test in Nepalese women and its influence in reducing burden of cervical carcinoma in Nepal. were mostly found in women having more than 3 children (1.2%, 2.8% and 0.4% respectively) ( Table 1 ).
MATERIAL AND METHODS
The women enrolled in the study were mostly Hindu (79.8%) and urban residents (76.3%). The most common symptom was vaginal discharge (41.6%) followed by pain abdomen (23.1%), irregular menstrual bleeding (9.9%), post-menopausal bleeding (4.5%), post-coital bleeding (4.2%), urinary frequency (3.2%) and something coming out of vagina (1.6%). A total of 108 cases (12%) were asymptomatic ( Table 2 ). The incidence of LSIL was higher in patients complaining of vaginal discharge (1.8%) whereas HSIL was found in patient complaining of irregular menstrual bleeding, post coital bleeding and in asymptomatic cases. The pap smear was negative for 52.3% of patients whereas 39.2% of patient showed inflammatory changes. The mean age of epithelial abnormality in our study was 47.88 ± 8.87 years.
In our the study group, age of first childbirth was highest in age group above 20 years (90.1%). In the study, Cervical epithelial cell abnormality was found in 5.6% of patients with age at marriage age ≤18 years as compared to 9.3% of patients with age at marriage age >18 years and this , which doesn't show any statistically significance difference (p-value=0.058). However, women having more than two children showed statistically significant epithelial cell abnormality as compared to women having two or less children (p-value ≤<0.001) as shown in Table 3 .
DISCUSSION
The incidence of cervical carcinoma and pap smear coverage is not adequately studied in Nepal. There is no data available at national level regarding pap smear coverage as it is not the recommended screening test for cervical cancer prevention in the "National cervical cancer prevention policy of Nepal". 2 Out of 902 patients, the incidence of ASCUS was found to be 2.3%, LSIL 5.3% and HSIL 0.8% percent. Populationbased study done in Bharatpur, Nepal by Sherpa AT et. al. found ASCUS in 2.8%, LSIL in 0.2% and HSIL in 0.5% patients which is lower as compared to our hospital based study. 10 Similar hospital-based study done in Uttar Pradesh, India showed ASCUS in 2.9%, LSIL in 5.09% and HSIL in 0.48% of screened women. 11 In our study, epithelial cell abnormality was found to be 8.4% which is comparable to studies done by Sachan In our study, epithelial cell abnormality was found in 17.11% of patients with parity two or less and 82.89% with parity more than two as compared to study done in Bangladesh by Banik U et al. which showed 17.27% and 82.73% respectively. 14 The most common symptom was vaginal discharge (23.2%) followed by pain abdomen (11.9%) and irregular menstrual bleeding (5.1%). This is in concordance to a study done in Uttar Pradesh, India which showed vaginal discharge in 39.96%, pain abdomen in 26.63% and irregular menstrual bleeding in 12.78 percent. 11 The incidence of ASCUS was higher (0.6%) in patients complaining of pain abdomen whereas LSIL was higher (1.8%) in patients with vaginal discharge and HSIL in patients with irregular bleeding (0.2%) and post-coital bleeding (0.2%) comparable to other study. 11 In context of Nepal, pap smear screening test is usually done in symptomatic patients by gynecologist as part of investigation. Therefore, screening facilities should be extended to primary health center level to increase the coverage of cervical screening and early diagnosis of premalignant and malignant lesion in asymptomatic patients.
CONCLUSIONS
Pap smear testing is noninvasive, sensitive and simple screening test for cervical premalignant and malignant lesions. The burden of cervical carcinoma can be reduced by screening patients visiting gynecological department and by inclusion of pap smear testing in national programme.
Recommendations
We recommend sexually active female to undergo routine pap smear testing to reduce the mortality and morbidity related to cervical carcinoma. We recommend Nepal government to launch cancer screening programme and spread the health education regarding benefit of screening tests.
Limitation of Study
The study could have been better if all the risk factors of cervical carcinoma were retrospectively studied in relation to the outcome of pap smear testing.
